Abstract
Nowadays, genomic sequencing data are being generated at a speed that has outstripped the pace of annotation. Loss-of-function CRISPR screens have been used as a high-throughput approach to determine the functional relevance of individual genes in a specific phenotype by ablating gene expression on a genome-wide scale and studying the resulting phenotype alterations.1,2 This is made possible by combining the CRISPR-Cas9 gene editing system with libraries of single guide RNAs (sgRNAs), which are ideally designed to target every gene in the genome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
